Login

Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Onsdag 15 Januari | 09:06:43 Europe / Stockholm

Svenska | English

2024-04-19 17:10:00

Estimates compiled by Modular Finance on behalf of XVIVO Perfusion.

Number of contributors: 6 (all of which have been updated or confirmed before the report)

KPI	Q1 2024E
Net sales (MSEK)	165
Organic growth in local currency (%)	15.8
Gross profit (MSEK)	123
EBIT (MSEK)	9
EBITDA (MSEK)	26
Net profit (MSEK)	8
Earnings per share (SEK)	0.25
Net sales per segment:
Thoracic (MSEK)	103
Abdominal (MSEK)	40
Services (MSEK)	22

XVIVO Perfusion’s Q1 report will be released on Wednesday, 24 April, at 07:30 am CEST.